首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Sharing clinical research data in the United States under the health insurance portability and accountability act and the privacy rule
【2h】

Sharing clinical research data in the United States under the health insurance portability and accountability act and the privacy rule

机译:根据健康保险可移植性和责任制法案以及隐私规则在美国共享临床研究数据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sharing of final research data from clinical research is an essential part of the scientific method. The U.S. National Institutes of Health require some grant applications to include plans for sharing final research data, which it defines as the factual materials necessary to document, support, and validate research findings. In the U.S., however, the Privacy Rule adopted under the Health Insurance Portability and Accountability Act impedes the sharing of final research data. In most situations, final research data may be shared only where all information that could possibly be used to identify the subject has been deleted, or where the subject has given authorization for specific research, or an Institutional Review Board has granted a waiver.
机译:共享来自临床研究的最终研究数据是科学方法的重要组成部分。美国国立卫生研究院要求某些赠款申请包括共享最终研究数据的计划,该计划将其定义为记录,支持和验证研究结果所必需的事实材料。但是,在美国,根据《健康保险可移植性和责任制法案》采用的隐私权规则阻碍了最终研究数据的共享。在大多数情况下,只有在删除了所有可能用于识别受试者的信息,受试者已授权进行特定研究或机构审查委员会放弃豁免的情况下,才能共享最终研究数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号